Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
257 Leser
Artikel bewerten:
(1)

Health Advance Inc Awarded Distributorship for Government Approved COVID Rapid Test

Health Advance Commercial Activity Picks Up Pace

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Health Advance, Inc (OTC PINK:HADV) www.HealthAdvanceGroup.com has been awarded shared distributorship, with select other companies, of the Rapid Response brand COVID-19 Antigen Rapid Test Device, released by BTNX, Inc. Involvement by Health Advance in sales of approved COVID testing device(s) lays the foundation for Health Advance's Inc product development to relieve symptoms of "Long COVID" - the lingering, long-term effects of infection on patient well-being - a burgeoning problem.

Health Advance Inc has earned this approval to participate in the distribution system of the Antigen Rapid Test by means of Health Advance's demonstrated track record of sales and training competence, for this product, in real world conditions, during an evaluation period.

Text, letterDescription automatically generated

Photo Caption: COVID-19 Antigen Rapid Test Device package of product for which Health Advance Inc has been granted shared distributor rights October 12, 2021

The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset and from individuals without symptoms or other epidemiological reasons to suspect COVID-19 infection, when tested twice over two (or three) days with at least 24 hours (and no more than 36 hours) between tests. It is approved by governments in various jurisdictions, and purchased by them, as well as by health care providers and patients themselves.

Health Advance will operate its distribution of the Rapid Response product through a joint venture structure to be announced separately, notwithstanding the fact that initial sales by Health Advance have now started.

ABOUT HEALTH ADVANCE INC: Since its founding in 2010, Health Advance Inc has targeted health and appearance related concepts. In 2021, Health Advance's new management committed to innovate Health Advance service to its shareholders and customers. Health Advance is now a Current Information tier filer with OTC Markets in the Alternative Reporting Guideline category as the basis of expanded operations. Through a new subsidiary, to be integrated into reporting in Q4 2021, Courtship Wines, HADV is targeting the launch of CBD infused beverages, starting in New York State. Health Advance Inc is organizing its commercial initiatives in partnership with external business affiliates, including Winning Brands Corporation (OTC: WNBD), in arrangements that will provide mutual benefits, including but not limited to royalties, consulting fees and management support by those parties and to those parties. These will be announced from time-to-time in concert with project developments.

Safe Harbor: Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

CONTACT:
Larry McLachlin, President
Health Advance, Inc
9131 Keele Street, Suite A4
Vaughan, Ontario L4K 0G7
(705) 733-7098
President@HealthAdvanceGroup.com
www.Twitter.com/HADVPresident

SOURCE: Health Advance Inc



View source version on accesswire.com:
https://www.accesswire.com/667812/Health-Advance-Inc-Awarded-Distributorship-for-Government-Approved-COVID-Rapid-Test

© 2021 ACCESS Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.